1 pahu (10 Vials)
| Loaʻa: | |
|---|---|
| Ka nui: | |
▎ He aha ka Melanota ?
ʻO Melanota kahi peptide anabolic synthetic e hoʻolalelale i ke kaʻina hana tanning ma o ka hoʻoulu ʻana i nā melanocytes e hana i ka melanin, e hiki ai i ka ʻili ke loaʻa i kahi ʻeleʻele ʻeleʻele i ka manawa pōkole-ʻoiai me ka liʻiliʻi o ka ʻike UV. Kōkua ia e hōʻemi i ka pōʻino o ka ʻili i hoʻoiho ʻia e UV, e hoʻohaʻahaʻa i nā pilikia o ka maʻi maʻi ʻili a me ka lā. Hoʻohui hou, hui pū ʻo Melanota me nā mea hoʻokipa melanocortin e hoʻoponopono i ka makemake e hoʻopau i ka pōloli, e kōkua ana i ka mālama kaumaha. Hōʻike pū ia i ka hiki ke hoʻoulu i nā kūkulu kāne kāne a me ka libido, a me ka hoʻonui ʻana i ka makemake moe wahine i loko o nā ʻano lāʻau lapaʻau, e hāʻawi ana i kahi hopena hou no ka hana ʻino. Hāʻawi kēia peptide i ka poʻe ʻili maikaʻi me kahi ala ʻoi aku ka palekana a ʻoi aku ka maikaʻi o ka tanning ʻoiai e hōʻike ana i nā ala therapeutic hou no ka libido haʻahaʻa a i ʻole erectile dysfunction i nā kāne ʻelua. Hiki iā ia ke hoʻoikaika i nā hana pale kūlohelohe o ka ʻili i ka pōʻino i hoʻoiho ʻia e UV, e pale ana i ke olakino ʻili lōʻihi.
▎ Melanotan-2 Hoʻolālā
Puna: PubChem |
Kaʻina: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH₂ Ke Kumu Molekala: C 50H 69N 15O9 Kaumaha Molekala: 1024.2 g/mol Helu CAS: 121062-08-6 PubChem CID: 92432 Synonyms: MT-II |
▎ ʻImi Melanotan-2
He aha ke kumu noiʻi o Melanota?
ʻO Melanota kahi analogue synthetic. He analogue synthetic ia o ka α-melanocyte-stimulating hormone (α-MSH), i hoʻomākaukau ʻia e nā ʻano hana synthesis kemika [1] . ʻO ka α-MSH kahi hormone kūlohelohe i loaʻa nā hana physiological like ʻole i ke kino o ke kanaka, me ka hoʻoponopono ʻana i ka pigmentation ʻili. Ua hoʻolālā ʻia ʻo Melanota e hoʻohālike i kekahi o nā hopena o ka α-MSH akā ʻoi aku ka ikaika o ka hana a me nā kumu noi kikoʻī. Ua hoʻokumu mua ʻia ʻo Melanota ma ke ʻano he mea e hoʻoikaika ai i ka pigmentation ʻili, ʻo ia hoʻi, kahi mea i kapa ʻia he tanning agent. Me ka piʻi ʻana o ka makemake o ka poʻe no ka tanning, ua hoʻomaka kekahi poʻe e ʻimi e loaʻa kahi hopena ʻeleʻele wikiwiki o ka ʻili ma o ka hoʻokomo ʻana iā Melanota. ʻO ka noiʻi e pili ana i kēia mea e pili nui ana i kāna hana a me ka hopena i ka pigmentation ʻili. No ka laʻana, ua ʻike nā haʻawina e hiki i ka Melanota ke hoʻopaʻa i nā mea loaʻa kikoʻī ma nā melanocytes e hoʻoulu i ka hana ʻana o ka melanin, a laila e pōʻeleʻele ai ka ʻili [2, 3].
He aha ka Melanota ?
ʻO Melanota kahi analogue synthetic e pili ana i ka α-melanocyte-stimulating hormone (α-MSH). ʻO kāna hana nui ka hoʻonui ʻana i ka pigmentation o ka ʻili a me ka pōʻeleʻele o ka ʻili kanaka. Hoʻohana nui ʻo Melanota i kona hopena ma ka launa pū ʻana me nā mea hoʻokipa melanocortin. ʻO ka mea kūikawā, ma ke ʻano he melanocortin receptor agonist koho ʻole, hiki iā ia ke hoʻoulu i ka hana ʻana o ka melanin i ka ʻili, no laila e loaʻa ai ka pigmentation ʻili, ʻo ia hoʻi, ka hopena tanning. Eia kekahi, hiki iā ia ke hana i ka penile erection spontaneous a me nā hopena hoʻoulu wahine.
He aha ke ʻano kikoʻī o Melanota i ka tanning?
Hoʻoulu ʻo Melanota i ka ʻili ʻili ma ka launa pū ʻana me ka melanocortin 1 receptor ma nā melanocytes. Manaʻoʻiaʻo Melanota e hoʻohālike i ka hopena o ka melanocortin α-melanocyte-stimulating hormone (α-MSH) ma ka MC1 receptor of melanocytes, e hopena i ka hoʻonuiʻana i ka hōʻike o ka protein hōʻailona agouti. Hoʻoulu ʻo Melanota i nā melanocytes e hana a huna i ka melanin, ma laila e hoʻonui ai i ka pigmentation ʻili [4] . Hiki iā ia ke hoʻoikaika i ka hana ʻana o ka eumelanin i ka ʻili e hoʻokō i ka pigmentation ʻili. Ua hōʻike ʻia nā haʻawina ʻo ka α-melanocyte-stimulating hormone (α-MSH) analogue cyclic - [Ac-Nle(4), Asp(5), D-Phe(7), Lys(10)] alpha-MSH-(4 - 10) amide (Melanota ), he potent melanocortin receptor agonist, hiki ke hoʻoikaika i ka hana ʻana o ka ʻili . .
He aha ke ʻano kikoʻī o Melanota i ka hoʻoulu ʻana i ka penile a hoʻonui i ka hoʻoulu ʻana i ka wahine?
Induction o ke kukulu ana:
I nā ʻiole i hoʻomaʻamaʻa ʻia, ʻo Melanota - kahi melanocortin receptor agonist ʻole i hōʻike ʻia - hōʻike ʻia i ka induction erectile e pili ana i ka dosis i ka wā i lawelawe ʻia ma o ka injection intravenous (0.1-1 mg / kg) a i ʻole hypothalamic paraventricular nucleus infusion (0.1-1 μg). ʻO kēia hopena i hoʻoulu i ka penile erections a hoʻemi i ka latency o nā hanana erectile mua [6] . Hiki i kona hopena ke komo i ka hoʻouluʻana i nā melanocortin receptors i loko o ke kikowaena pūnaewele, a laila e hoʻoponopono i nā ala neural e pili ana i ke kūkuluʻana. Ke hoʻokomo ʻia ʻo Melanota intrathecally (0.2 μg) ma ka pae L6 - S1, ʻoi aku ka kiʻekiʻe o ka amplitude o nā hanana kūkulu. Hōʻike kēia i nā ala neural ma ka pae o ke kuamoʻo e komo pū i ka hoʻokomo ʻana o ke kūkulu ʻana e Melanota [6].
Hoʻolaha i ke kūkulu ʻana:
Ma hope o ka hoʻokomoʻiaʻana o Melanota (1 mg / kg), ua hoʻonuiʻia ka pane erectile i hoʻouluʻia e ka hoʻouluʻana o ke aʻalolo cavernous, a pēlā e pāʻani ai i ka hana hoʻolaha i ke kūkuluʻana [6] . Ma hope o ka wehe ʻana i ke kaulahao aloha lumbar paravertebral, ua hoʻopau ʻia ka hopena hoʻolaha o Melanota. Hōʻike kēia i ka hopena hoʻolaha o Melanota ma ke kūkulu ʻana ma muli o ka pono o ke kaulahao aloha lumbar paravertebral. ʻO ka hoʻohālikelike, ʻaʻole i hōʻike ʻia ʻo Melanota i loko o ka corpus cavernosum (1 μg) i kekahi hana hoʻolaha. ʻO ka transection spinal cord a i ʻole ka bilateral transection o ke aʻalolo pelvic a i ʻole ke aʻalolo hope o ka penis ʻaʻole ia i hoʻopilikia i ka hana hoʻoikaika ʻana o ka Melanota intravenous (1 mg / kg), e hōʻike hou ana i ka hopena o ka hoʻoikaika ʻana o Melanota ma ke kūkulu ʻana ma o ke ala aʻalolo aloha ma mua o ke aʻalolo pelvic a i ʻole ke aʻalolo dorsal o ka penis [6]..
ʻO ka hoʻonui ʻana i ka hana hoʻoulu wahine:
Ua ʻike nā haʻawina he hopena nō hoʻi ʻo Melanota i ka moe kolohe wahine. I nā ʻiole wahine, ua hoʻonui ʻia nā ʻiole ovariectomized me ka estradiol benzoate (EB) a me ka progesterone (P), ka hoʻokomo ʻana o Melanota (1 a me 3 mg / kg) i ka nui o nā lele, wikiwiki, a me nā wiggles pepeiao, e hōʻike ana e hiki i ka progesterone ke launa pū me Melanota e hoʻonui i ka hana hoʻoulu wahine [7].

Ka hopena o MTII ma ka tumorigenicity o nā melanoma cell.
Puna:PubMed [1]
ʻO Melanota kahi mea me nā hana he nui a me nā kuhikuhi noiʻi. E hoʻolauna ʻia nā noiʻi ʻē aʻe e pili ana ma Melanota.
Induction o ke kukulu ana:
Ma kekahi mau haʻawina, ua ʻike ʻia he hopena pū kekahi Melanota i ka ʻōnaehana hānau. No ka laʻana, hiki i ka Melanota ke hana i ke kūkulu ʻana o ka penile. Ua ʻike kekahi poʻe maʻi i ke kūkulu ʻana i ka ʻeha ma hope o ka hoʻokele subcutaneous o Melanota, a ua hōʻike pū kekahi i nā hōʻailona o ka hoʻoulu ʻana o ke aʻalolo aloha, e like me ka piʻi ʻana o ka puʻuwai, piʻi ʻana o ke koko, hoʻomaha ʻole, a me ka sweating nui [8] . Eia kekahi, ma nā haʻawina e pili ana i nā rodents, hiki i nā mea melanocortin ke hana i ka lordosis posture, i unuhi ʻia he hōʻike o ka hoʻonui ʻana i ka hoʻoulu ʻana i ka moe kolohe [8] , e hōʻike hou ana e pili ana ka hopena o Melanota i ka ʻōnaehana reproductive e pili ana i ka hoʻoulu wahine a me ka hoʻoponopono ʻana i ka moe kolohe.
Hoʻonui i ka hana melanin:
Ma keʻano he melanocortin synthetic analogue, hiki iā Melanota ke hoʻopaʻa i ka melanocortin I receptor (MC1R) e hoʻoikaika i ka hana melanin [9] .Hoʻokō nui ia i kēia ma ka hoʻonui ʻana i ka melanocytes a me ka hoʻoponopono ʻana i ka hana o tyrosinase. ʻO kēia hopena o ka hoʻolaha ʻana i ka hana melanin e hāʻawi iā Melanota i ka waiwai hoʻohana pono i ke kahua o ka ʻili, no ka laʻana, hiki ke pāʻani i ka mālama ʻana a me ka pale ʻana i kekahi mau maʻi ʻili.
Ka noiʻi ma nā ʻano anti-tumor:
Ma ka noiʻi e pili ana i ka anti-tumor, ua ʻike nā haʻawina e hoʻohana ana i ka B16-F10 melanoma model ʻoiai ʻaʻohe hopena o Melanota i ka hoʻonui ʻana o nā pūnaewele melanoma, hiki iā ia ke pale pono i ka neʻe ʻana, ka hoʻouka ʻana, a me ka hiki ke hoʻokumu ʻana i nā kolo o nā pūnaewele melanoma. Hiki i ka noi kūloko o Melanota ke hoʻemi nui i ka piʻi ʻana o ka ʻiole i nā ʻiole me ka melanoma paʻa. ʻO kāna hana o ka hana, ʻo ia ka hoʻoulu ʻana o ka phosphatase a me ka tensin homolog (PTEN) ma o ka melanocortin 1 receptor (MC1R), a laila e pale ai i ka holomua o ka melanoma ma ka hoʻohaʻahaʻa ʻana i ke ala hōʻailona cyclooxygenase II (COX-2)/prostaglandin E2 (PGE2) [1].
Ka hopena lapaʻau ma ka autism:
Ua hoʻohana kekahi mau haʻawina i ka ʻiole maternal immune activation (MIA) o autism no ka loiloi ʻana i ka hiki ke hoʻōla o ka melanocortin receptor 4 agonist M Melanota no nā ʻano autism-like i nā ʻiole kāne makua [10] . ʻO ka hoʻokele ʻana o Melanota i nā ʻiole MIA kāne no ʻehiku mau lā i alakaʻi ʻia i ka hoʻomaikaʻi ʻana i nā hōʻailona o ka nohona. ʻAʻohe hoʻololi koʻikoʻi i nā hōʻailona hana pilikanaka i nā ʻiole kāne C57 me kahi kūlana maʻamau ma hope o ka mālama ʻana me Melanota. Eia hou, i nāʻiole C57 maʻamau,ʻaʻohe hoʻololi i ka hopohopo-like a iʻole ka hana houʻana ma hope o ka mālamaʻana me Melanota, akā, aia ka emi nui o ke kaumaha o ke kino ma hope o ka hoʻoponopono subacute. Hōʻike kēia mau ʻikepili he lāʻau lapaʻau maikaʻi ʻo Melanota e hiki ke hoʻomaikaʻi i nā hemahema ʻano like me ka autism ma ke ʻano autism o nā ʻiole MIA kāne makua.
Ka hoʻihoʻi ʻana o ka pōʻino hoʻomanaʻo:
Ua hōʻike nā haʻawina ua hōʻike ʻia kahi meaʻai momona kiʻekiʻe (HF) e hoʻonui i ka pilikia o ka hōʻino ʻana i ke aʻalolo a me nā maʻi neurodegenerative. Ua noiʻi kēia haʻawina i ka pilina ma waena o ka meaʻai, ʻo Melanota e ʻimi ana i nā melanocortin receptors, a me ka ʻano o ka iʻa zebrafish [11] . ʻO ka mea kupanaha, ʻo kahi ʻai HF pōkole i lōʻihi ma kahi o 1% o ke ola o ka iʻa zebra i loaʻa i kahi hopena ulu ikaika. Hoʻohālikelike ʻia me ka iʻa zebrafish i hānai i ka meaʻai hoʻomalu, hānai ʻia ka iʻa zebrafish i ka meaʻai HF i hōʻike i ka hoʻomanaʻo hoʻomanaʻo ʻana, hoʻonui i nā pae hopohopo, a hoʻemi i ka manaʻo ʻimi ma hope o ʻekolu pule wale nō. A ua hoʻohuli ʻia kēia mau mea ʻino i ka ʻai HF e Melanota. Ua hānai nā holoholona i ka meaʻai HF a mālama ʻia me Melanota i hōʻike i ka hoʻomanaʻo hoʻomanaʻo, ka hopohopo, a me nā ʻano ʻimi e like me nā ʻano o ka hui hoʻomalu. Hāʻawi kēia haʻawina i nā hōʻike e hiki ai i ka ʻai HF pōkole ke loaʻa ka hopena i ka hoʻomanaʻo a me ke ʻano, a ʻo ia ka haʻawina mua e hōʻike ai hiki iā Melanota ke hoʻohuli i kēia mau loli.
Hoʻoponopono i ka nohona pili kanaka:
Ma ke kahua o ka noiʻi neuroscience, ua ʻike ʻia e hiki i ka Melanotan-II ke hoʻoponopono i ka nohona pili kanaka ma o ka hoʻoulu ʻana i nā mea hoʻokipa melanocortin a laila hoʻāla i ka ʻōnaehana oxytocin kikowaena [12] . ʻO keʻano, ma hope o ka hoʻoponopono pūnaewele o Melanota, hiki ke hoʻoulu nui i ka'ōlelo Fos i loko o nā neurons magnocellular o ka nucleus supraoptic (SON) a me ka paraventricular nucleus (PVN) o ka hypothalamus, a hiki ke hoʻopauʻia kēia pane e ka pretreatment me ka melanocortin-91 antagonist antagonist. Ua hōʻike ʻia nā hoʻopaʻa leo electrophysiological e hiki ke hoʻonui i ka hoʻopiʻi ʻana o Melanota i ke ahi o nā neurons oxytocin i ke SON. Hōʻike kēia he hopena hoʻoponopono ka Melanota i ka ʻōnaehana oxytocin e pili ana i ka ʻano pilikanaka i loko o ka ʻōnaehana nūnū, a ʻo kāna ʻano hana paha e hoʻoponopono i ka hana a me ka huna ʻana o nā neurons oxytocin ma o ka hoʻāla ʻana i nā mea loaʻa a me nā ala hōʻailona.
Ka noiʻi e pili ana i ka momona a me ke olakino metabolic:
Ma ke ʻano o ka momona a me ke olakino metabolic, ua hoʻohana kekahi mau haʻawina i ke ʻano genetic o ka pituitary adenylate cyclase-activating polypeptide (PACAP) -deficient mice a ʻike ʻia hiki i ka melanocortin receptor agonist Melanota ke hoʻopakele i ka hiki ʻana o ka thermogenic impaired o PACAP-deficient mice i ka wā anuanu. Hōʻike kēia i hiki i ka PACAP ke hoʻokani i kahi hana i luna o ka ʻōnaehana melanocortin, e hoʻoponopono ana i ka hana nerve sympathetic o ka ʻiʻo adipose brown i nā ʻiole, a laila e loaʻa ai ka hopena i ka momona a me ke olakino metabolic [13].
Hoʻoponopono i ka metabolism a me ka mahana o ke kino:
He hopena koʻikoʻi ka Melanota i ka ʻōnaehana endocrine. Eia kekahi laʻana, hiki i ka lawelawe intraperitoneal o Melanota i nāʻiole ke hana i ka hypometabolism / hypothermia hohonu a transient [14] .Ua hōʻike nā haʻawina i nāʻiole nele i nā mast cell, ua hoʻopauʻia ka hypothermia i hanaʻia e Melanota, e hōʻike ana e koiʻia ke komoʻana o nā pūnaewele mast. Hoʻokumu ʻo Melanota i ka hypothermia i nā ʻiole ma o ka hoʻoulu ʻana i nā mast cell a me ka hoʻoulu ʻana i ka histamine 1 receptor, a ʻo kāna ʻano hana e pili ana i ka pilina o nā mea endocrine lehulehu a me nā mea loaʻa.
I ka hopena, ma ke ʻano he mea synthetic i huki nui ʻia, hōʻike ʻo Melanota i nā hiʻohiʻona kūʻokoʻa i nā ʻano he nui. Ma ke kahua o ka ʻili, ma ka hoʻopaʻa ʻana i nā mea loaʻa kikoʻī ma nā melanocytes, hiki iā ia ke hoʻoikaika maikaʻi i ka hana ʻana o ka melanin, me ka hāʻawi ʻana i kahi ʻano tanning non-traditional no ka poʻe makemake i ka ʻili keleawe olakino. Ke hoʻohālikelike ʻia me ka tanning e ka lōʻihi o ka ʻike ʻana i nā kukuna ultraviolet, hiki iā Melanota ke pale i ka pōʻino pololei o nā kukuna ultraviolet i ka ʻili a hōʻemi i nā pilikia o ka sunburn, ʻelemakule ʻili, a me ka maʻi maʻi ʻili.
Mai ka hiʻohiʻona o ka hoʻoponopono ʻana i ka hana moe kolohe, loaʻa ka Melanota i ka hopena maikaʻi i ka hoʻoulu ʻana i ka penile a me ka hoʻonui ʻana i ka hoʻoulu ʻana. He hopena maikaʻi kēia no kekahi poʻe me ka moe kolohe a i ʻole ka poʻe i manaʻo e hoʻomaikaʻi i kā lākou ʻike moe kolohe. Hiki iā ia ke hoʻokō i kahi hopena maikaʻi i ka hana moe kolohe ma o ka hoʻoulu ʻana i nā ala neural kikoʻī i loko o nā ʻōnaehana nerve waena a peripheral a me ka hoʻoponopono ʻana i nā neurotransmitters pili a me nā mea loaʻa, e hāʻawi ana i nā mea hou no ka hoʻomaikaʻi ʻana i ke olakino wahine.
Ma ka noiʻi e pili ana i ka momona a me ke olakino metabolic, hōʻike pū ʻia ʻo Melanota i nā pono kūpono. Hiki iā ia ke hoʻoponopono i ka metabolism ikehu a me ka mahana o ke kino a loaʻa kekahi hopena hoʻomaikaʻi i ka hana impaired o adipose tissue i ka momona. Hāʻawi ia i kahi kuhikuhi noiʻi hou no ka mālama ʻana i ka momona a me ka mālama ʻana i ke olakino metabolic, kahi mea kōkua no ka hoʻomohala ʻana i nā hoʻolālā lapaʻau hou a me ka hoʻomaikaʻi ʻana i ke kūlana olakino o nā maʻi obese.
No ka mea kakau
ʻO nā mea i ʻōlelo ʻia ma luna nei ua noiʻi ʻia, hoʻoponopono ʻia a hōʻuluʻulu ʻia e Cocer Peptides.
Mea kākau moʻolelo ʻepekema
ʻO Cousen, P he mea noiʻi me ka manaʻo nui i ke kahua o ka Dermatology Allergy. Ua hui pū ʻia kāna hana i loko o kēia kahua me kekahi mau hui, me ka South Tees Hosp NHS Fdn Trust, James Cook University Hospital, Royal Cornwall Hospital, University of Sheffield, a me Chesterfield Royal Hosp. Ma waho aʻe o kāna ʻoihana koʻikoʻi ma Dermatology Allergy, Cousen, ʻo nā makemake noiʻi a me nā hana a P e hoʻonui ʻia i nā wahi e pili ana e like me ka immunology, i hāʻawi ʻia i ka pilina ma waena o nā hopena maʻi a me ka ʻōnaehana pale. E pili ana paha kēia i ke aʻo ʻana i nā pane kūlohelohe e alakaʻi ai i nā maʻi ʻili a me ka ʻimi ʻana i nā ala lapaʻau hou e hoʻololi i kēia mau pane.
Eia hou, hiki i kāna noiʻi ke hoʻopili i nā hoʻokolohua lapaʻau no nā lāʻau dermatological hou, ke aʻo ʻana i ka hana pale ʻili a me kāna kuleana i ka pale ʻana i ka maʻi allergy, a me ka hoʻokolokolo ʻana i nā kumu genetic e predispose i nā kānaka i ka ʻili allergies. Eia kekahi, e noʻonoʻo ana i ke ʻano multidisciplinary o ka noiʻi mālama olakino, hiki iā ia ke hana pū me nā loea mai nā ʻano ʻē aʻe e like me ka lāʻau lapaʻau, microbiology (ke aʻo ʻana i ka hopena o ka microbiome ʻili i nā maʻi allergies), a me ka psychology (e nānā ana i ka hopena noʻonoʻo o nā maʻi ʻili mau loa), a laila e hāʻawi i ka ʻike piha a me ka mālama ʻana i nā maʻi maʻi dermatological. Ua helu ʻia ʻo Cousen, P ma ka ʻōlelo kuhikuhi [4].
▎ Nā ʻōlelo pili
[1] Langan EA, Nie Z, Rhodes L E. Melanotropic peptides: ʻoi aku ma mua o ka 'Barbie drugs' a me nā 'sun-tan jabs'?[J]. British Journal of Dermatology, 2010,163(3):451-455.DOI:10.1111/j.1365-2133.2010.09891.x.
[2] Humphrey SM, Oo T, Barnetson SC. Hiki i ke kino o Melanota® (NDP-α-MSH) i ka pale ʻana i ka ʻili -: kūlana o kēia manawa a me ka manaʻo e hiki mai ana [J]. Hoʻokolohua Dermatology, 2004,13 (9): 578.
[3] Perez-Bootello J, Cova-Martin R, Naharro-Rodriguez J, et al. Vitiligo: Pathogenesis a me nā lāʻau lapaʻau hou a e puka mai ana [J]. Ka Nupepa International of Molecular Sciences, 2023,24(24).DOI:10.3390/ijms242417306.
[4] Kim ES, Garnock-Jones K P. Afamelanotide: He Manaʻo ma Erythropoietic Protoporphyria [J]. American Journal of Clinical Dermatology, 2016,17(2):179-185.DOI:10.1007/s40257-016-0184-6.
[5] Minder A, Schneider-Yin X, Zulewski H, et al. Hoʻopili ʻia ʻo Afamelanotide me ka hopena palekana e pili ana i ka dosis mai ka pōʻino o ke ake e pili ana i ka Erythropoietic Protoporphyria [J]. Ola-Basel, 2023,13(4).DOI:10.3390/life13041066.
[6] Dorr RT, Ertl G, Levine N, et al. ʻO nā hopena o kahi peptide melanotropic superpotent i hui pū ʻia me ka hoʻoheheʻe ʻana o ka lā ma luna o ka ʻili o ka ʻili i nā mea manawaleʻa kanaka [J]. Archives of Dermatology, 2004,140(7):827-835.DOI:10.1001/archderm.140.7.827.
[7] Reid C, Fitzgerald T, Fabre A, et al. Atypical melanocytic naevi ma hope o melanotan injection.[J]. ʻO Irish Medical Journal, 2013,106 (5): 148-149. https://pubmed.ncbi.nlm.nih.gov/23914578/
[8] Dominguez-Mozo MI, Toledano-Martinez E, Rodriguez-Rodriguez L, et al. ʻO ka hoʻoulu hou ʻana o ka maʻi JC i nā maʻi me nā maʻi rheumatic autoimmune i mālama ʻia me rituximab [J]. Scandinavian Journal of Rheumatology, 2016,45(6):507-511.DOI:10.3109/03009742.2015.1135980.
[9] Wu V, Sykes EA, Beyea MM, et al. Hoʻopili i ka mea hoʻohana e hāʻawi i ka makana ma ka uku o ka maladie de Ménière. Kauka ʻohana Kanada Medecin De Famille Canadien, 2019,65(7):468-472. https://pubmed.ncbi.nlm.nih.gov/31300427/
[10] McNeil MM, Nahhas AF, Braunberger TL, et al. ʻO Afamelanotide i ka mālama ʻana i ka maʻi Dermatologic [J]. Palapala Hoʻomaʻamaʻa ʻili, 2018,23(6):6-10. https://pubmed.ncbi.nlm.nih.gov/30517779/
ʻO nā ʻatikala a me nā ʻike huahana i hāʻawi ʻia ma kēia pūnaewele pūnaewele wale nō no ka hoʻolaha ʻana i ka ʻike a me nā kumu hoʻonaʻauao.
ʻO nā huahana i hāʻawi ʻia ma kēia pūnaewele i manaʻo wale ʻia no ka noiʻi in vitro. Hana ʻia ka noiʻi in vitro (Latin: *i ke aniani*, ʻo ia hoʻi i ka ipu aniani) ma waho o ke kino kanaka. ʻAʻole kēia mau huahana he lāʻau lapaʻau, ʻaʻole i ʻae ʻia e ka US Food and Drug Administration (FDA), a ʻaʻole pono e hoʻohana ʻia no ka pale ʻana, mālama, a hoʻōla paha i kekahi maʻi olakino, maʻi, a maʻi paha. Ua pāpā loa ʻia e ke kānāwai ke hoʻokomo i kēia mau huahana i loko o ke kino kanaka a holoholona paha ma kekahi ʻano.